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Background: Spatial neglect is a frequent and debilitating consequence of acquired brain injury and currently has
no widely accepted standard of care. While previous interventions for spatial neglect have targeted patients’ overt
spatial deficits (e.g., reduced contralesional visual scanning), far fewer have directly targeted patients’ non-spatial
deficits (e.g., sustained attention deficits). Considering that non-spatial deficits have shown to be highly predictive
of long-term disability, we developed a novel computer based training program that targets both sustained (tonic)
and moment-to-moment (phasic) aspects of non-spatial attention (Tonic and Phasic Alertness Training, TAPAT).
Preliminary studies demonstrate that TAPAT is safe and effective in improving both spatial and non-spatial attention
deficits in the post-acute recovery phase in neglect patients. The purpose of the current trial (referred to as the
REmediation of SPatial Neglect or RESPONSE trial) is to compare TAPAT to an active control training condition,
include a larger sample of patients, and assess both cognitive and functional outcomes.
Methods/Design: We will employ a multi-site, longitudinal, blinded randomized controlled trial (RCT) design with a
target sample of 114 patients with spatial neglect. Patients will either perform, at their home, the experimental
TAPAT training program or an active control computer games condition for thirty minutes/day, five days a week,
over three months. Patients will be assessed on a battery of cognitive and functional outcomes on three occasions:
a) immediately before training, b) within forty-eight hours post completion of total training, and c) after a three-month
no-contact period post completion of total training, to assess the longevity of potential training effects.
Discussion: The strengths of this protocol are that it tests an innovative, in-home administered treatment that
targets a fundamental deficit in neglect, employs highly sensitive computer-based assessments of cognition as
well as functional outcomes, and incorporates a large sample size (relative to other neglect treatment studies) in
an RCT design.
Trial registration: ClinicalTrials.gov identifier, NCT01965951
Keywords: Hemispatial neglect, Rehabilitation, Non-spatial attention, Stroke, Computer-based cognitive trainingBackground
Approximately one half to two thirds of all patients with
right hemisphere injury due to an acquired brain injury
(ABI) exhibit a complex, debilitating array of neuro-
logical deficits known as the spatial neglect syndrome
(referred to henceforth as neglect). Neglect refers to a
collection of related spatial and non-spatial attention* Correspondence: tom.vanvleet@positscience.com
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stated.deficits that can occur after damage or disconnection to
any number of interconnected cortical or subcortical areas
(e.g., inferior parietal and frontal regions), usually in the
right hemisphere [1-8]. While the severity of impairment
can vary [9], the most obvious problem is that patients
present with an inability to respond to stimuli on the
contra-lesional or neglected side of space, often seemingly
unaware that anything in that space exists [10]. Patients
commonly suffer from poor navigation, bumping into
objects or walls or disregarding potentially hazardousral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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also exhibit deficits in attention that are not spatially
lateralized. For example, they often show deficits in
alertness-based, time-challenged successive signal rec-
ognition, working memory, and sustained non-spatial
attention [11-14].
Interestingly, non-spatial attention deficits are stron-
ger predictors of chronic spatial neglect than are the
visuo-spatial deficits themselves [12,13,15-17]. Fur-
thermore, several recent studies and theoretical models
indicate that poor regulation of intrinsic alertness can
explain the severity of spatial bias in these patients
[15,18-21]. In addition to these spatial and non-spatial
attention deficits, reduced intrinsic alertness and im-
paired sustained attention can undermine more gen-
eral cognitive functions such as memory and executive
functions. By addressing patients’ non-spatial symp-
toms, it may be possible to not only improve their
spatial biases, but also enhance higher-level cognitive
functioning.
Several experimental therapies designed to remediate
neglect have been developed over the last 30+ years.
Behavioral treatments that target increased visual
scanning in a top-down manner have shown some ef-
fectiveness, but may be overly time-consuming and
may not be appropriate with patients who lack deficit
awareness (i.e., anosognosia) [22]. Prism adaptation, a
more bottom-up approach, has shown to improve left-
ward hypokinesis though it is unclear whether it can
consistently improve more general neglect symptoms
[23]. Mixed results have been found with pharmaco-
logical interventions that increase alertness, but two
recent demonstrations with rotigotone and guanfacine
suggest some benefit [24]. Finally, recent studies employ-
ing non-invasive brain stimulation (theta burst transcra-
nial magnetic stimulation) to reduce activity in the intact
hemisphere and improve functional outcomes have been
quite promising [24].
Despite some evidence of benefits from these treat-
ments, most largely fail to target patients’ non-spatial
attention deficits. These non-spatial deficits are particu-
larly important because they are significantly related to
the chronicity of neglect. Pharmacological treatments
may boost overall arousal/alertness levels but they have
not shown to specifically improve moment-to-moment
or sustained attention abilities in neglect patients. Thus,
to address patients’ non-spatial deficits, we have devel-
oped a treatment targeting both sustained (tonic) and
moment-to-moment (phasic) aspects of attention (tonic
and phasic alertness training, TAPAT). TAPAT is a con-
tinuous performance task in which all stimuli are pre-
sented at central fixation (i.e., within a well-represented
area of spatial awareness) with several key elements that
help patients stay engaged such as jittered inter-trialintervals [25], rich, colorful, and novel stimuli, and a
response inhibition component.
The results of our two previously published studies with
approximately five hours of either visual or auditory
TAPAT training over three weeks (10 sessions × 36 mins/
session) are notable [26,27]. Not only did neglect patients
demonstrate improvements in moment-to-moment and
sustained attention after training, but they also showed
more general improvements in sensitive measures of
object-based attention and visual search. These initial
studies of TAPAT demonstrate that enhancing non-
spatial attention abilities can transfer to more general
neglect symptoms (e.g., improvements in visuospatial
search). The current multi-site clinical trial extends
these studies with a longer duration of TAPAT training
(8 weeks instead of 2 weeks), the inclusion of an active
control training condition, a three-month follow-up visit
to assess carryover effects, and the inclusion of additional
computer-based, standard neuropsychological and func-
tional outcome measures.
Two additional innovations in the protocol for the
current clinical trial are notable. First, to our knowledge
the current trial is the first, and perhaps the only
Internet-based treatment for hemispatial neglect, de-
signed to be completed in-home with minimal supervi-
sion. Of the eleven randomized clinical trials that have
been completed in neglect (with adequate blinding) none
have utilized computer-based cognitive training programs
[28]. The advantages of computer-based training programs
are that they can be performed at home via the Internet
and, compared to pharmacological approaches, have min-
imal side effects (i.e., determined to be non-significant risk).
Furthermore, computer-based training can be adaptively
tailored to individual patient’s abilities to provide the appro-
priate amount of challenge. Finally, Internet-based training
allows researchers and clinicians to remotely supervise
training activities of multiple participants in real-time.
The second notable innovation in the current proto-
col relates to the use of several highly sensitive, reli-
able, and valid computer-based measures designed
specifically for this population; that were not included
in previous clinical trials. For example, the computer-
based conjunction search task has shown to be a highly
sensitive measure of goal-directed attention, revealing
latent neglect symptoms in individuals who otherwise
failed to show neglect on classic paper and pencil tasks
[29]. These measures are not only more sensitive to re-
sidual impairments, but they also allow improved de-
tection of training-related benefits, thereby enabling a
more complete assessment of the extent to which pa-
tients’ deficits are partially versus fully addressed.
These measures also facilitate better detection of neg-
lect sub-types (i.e., behavioral profiling) to determine
which individuals respond best to treatment. This is
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neous disorder.
Aims and hypotheses
The aim of the current study is to test the effectiveness
of 16 hours of computer-based TAPAT training to im-
prove spatial neglect symptoms and enhance func-
tional outcomes. Secondary aims include measuring
the degree to which these effects persist after a three-
month no-contact period and determining which pa-
tients best respond to TAPAT. Based on our previous
findings, we predict that TAPAT will show large effect
sizes, benefits will generalize across a wide range of
neglect symptoms and functional outcomes, and these
effects will persist beyond the three-month no-contact
period. We hypothesize that those patients with the
greatest impairments at baseline (i.e., most severe neg-
lect), and those that demonstrate the most progress in
treatment will show the greatest benefits.Figure 1 Study outline.Methods/Design
Overall design and timeline
The current study will employ a multi-site, longitudinal,
blinded randomized controlled trial (RCT) design with a
target sample of 114 patients with neglect (see inclusion
criteria below). Fifty-seven patients with neglect com-
pleting TAPAT will be compared to fifty-seven patients
with neglect completing the active control condition
(computer-based games; see Figure 1). Total participa-
tion time is approximately six months and includes four
in-person assessment sessions. The first assessment ses-
sion (V0) involves screening for eligibility (see inclusion/
exclusion below). If the participant is eligible, they per-
form a baseline assessment (V1) to characterize their
spatial and non-spatial attention, as well as cognitive
and functional abilities before training. After the base-
line assessment, patients are randomized to either the
TAPAT or control training program and complete ap-
proximately twelve to sixteen weeks of in-home training,
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nitive remediation coach). To measure potential training-
related improvements, participants will be assessed within
48 hours after the completion of the total training (V2) by
an assessor that is blind to group affiliation. To measure
the persistence of potential training-related improvements,
participants are also assessed after a three-month no-
contact period (V3), again by an assessor blind to group
affiliation. After this visit, participant activities are com-
pleted and trial participation ends.
Study population
The study population is comprised of individuals with
spatial neglect following an acquired brain injury (ABI),
which may include stroke, tumor resection (without
chemotherapy or radiation within 36-months) or other
focal lesions.
Due to the average age of individuals with ABI (i.e.,
60–90 years) and the unpredictable consequences of
brain insult, we expect this population to have additional
challenges, including but not limited to vision and/or
hearing difficulties, motor difficulties (e.g., hemiakinesia,
hemiparesis) and other unrelated, pre-morbid medical
complications. We will only enroll individuals for whom
these complications will not interfere with assessment
procedures or completion of the training programs.
The following inclusion/exclusion criteria will be de-
termined through our screening procedures during V0,
which includes structured interviews, as well as comput-
erized and standardized neuropsychological assessments
of attention, cognition and functional abilities.
Inclusion criteria
1) Diagnosis of acquired brain injury will be confirmed
via neuroimaging results from patients’ medical
provider.
2) Diagnosis of Spatial Neglect will be confirmed by
deficient performance on at least two of four
common measures of Spatial Neglect:
 Mesulam cancellation task [30] (ages 50 and
younger > 0 omissions; 51–80 > 4 omissions)
 Dual task (>19% difference in accuracy for
right - left target trials) [31]. If performance on the
Dual Task – Dual does not yield a reliable result,
the task must be repeated. Upon repeating the task,
if it still does not yield a reliable result, inclusion
will be based on the performance on the remaining
measures, where performance on two of the three
must be consistent with neglect for the participant
to be included in the study (Figures 2 and 3).
 Tone Counting task [13] (< 94% total accuracy)
 Landmark task (Rightward deviation from objective
center significantly different from zero) [26].3) 18 years of age or older at the time of consent.
4) At least three months post most-recent-brain-injury
to minimize the effects of spontaneous recovery, as
verified via participant self-report.
5) Fluent spoken English by the age of 12 in the
judgment of the consenting clinician or as verified
via participant interview.
6) Participants must have adequate sensorimotor
capacity to participate in the trial, including visual
capacity, auditory capacity, and motor capacity
adequate to control a computer mouse.
Exclusion criteria:
1) A conjunction of prior acquired brain injury and
score > 8 on the Blessed Scale-Short form at Baseline
(i.e., residual cognitive impairment or dementia) [32].
2) Diagnosis of severe depression according to the Beck
Depression Inventory (BDI-II score >18) [33] at V0
3) Diagnosis of a chronic psychiatric disorder with
associated cognitive impairments (e.g.,
schizophrenia) as confirmed through a structured
clinical interview. Participants will not be excluded
due to variation on this measure post-screening or
worsening of depression.
4) Diagnosis of an illness, condition or treatment
(within 36-months of consent) with known cognitive
consequences (e.g., chemotherapy) verified through
clinical interview.
5) Participants who have answered ‘yes’ to:
 Question 5 (Active Suicidal Ideation with Specific
Plan and Intent) on the Columbia-Suicide Severity
Rating Scale (C-SSRS) [34] or,
 ‘Yes’ to any of the suicide-related behaviors
(actual attempt, interrupted attempt, aborted
attempt, preparatory act or behavior) on the
“Suicidal Behavior” portion will be excluded from
the study if the ideation or behavior occurred
within two months from Participant’s date of
consent (as recommended by the FDA for
treatment trials). Participants excluded for this
reason will be referred for appropriate treatment.
Further, participants meeting this criteria at any
time throughout the study will be asked to
complete a final assessment, if appropriate, then
withdrawn from the study and referred for
appropriate treatment.
6) Current or significant past history of substance
abuse in the judgment of the Site PI.
7) Difficulty completing assessments and/or
comprehending requirements of the trial (e.g.,
following verbal instructions).
8) Enrollment in a concurrent clinical trial involving an
investigational pharmaceutical, nutraceutical, medical
Figure 2 Spatial neglect screening protocol.
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outcome of this study will be excluded. Participants
will not be excluded for participation in conventional
treatments (e.g., physical or occupational therapy) or
use of prescribed medications.
9) Complete primary visual field deficit determined by
scoring a ‘3’ (bilateral anopsia) on the NIH Stroke
Severity Scale (NIHSSS) [35]:
a) 0 = no visual field deficit
b) 1 = partial hemianopsia
c) 2 = full hemianopsia
Repeated assessment battery
Once a participant is deemed eligible for participation
based on their V0 results, they are next then scheduled
for their baseline session on the repeated assessment bat-
tery (V1), which takes approximately two hours. After
completing this baseline assessment, participants arerandomly assigned to either experimental or control train-
ing conditions (see below). Then, immediately after total
training is completed, participants are given the repeated
assessment battery (V2) and again after a three-month no
contact period (V3).
The repeated assessment battery consists of a primary
outcome measure (conjunction search task [29,36]), which
measures the degree of bias in goal-directed spatial atten-
tion, and several secondary outcome measures. Secondary
outcomes include sensitive assessments of spatial cogni-
tion and more global cognitive functioning as well as daily
life measures of functional ability, quality of life, and sleep
(Table 1).
Spatial attention
The primary outcome, spatial attention, will be evalu-
ated using the conjunction search task [26,27,29]. The
conjunction search task (CS) requires participants to
Figure 3 A visual, within-category version of TAPAT.
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that share at least one feature (color or shape) with the
target (e.g., a red square target located amongst red tri-
angles and blue squares); see [26,27,29]. Thus, partici-
pants cannot simply search for the color or shape of the
target object (i.e., the so-called ‘pop-out’ effect), but are
required to engage in a serial search to find the unique
conjunction of shape and color.Table 1 Primary and secondary outcome measures
Domain Measure Primary/
Secondary
Spatial attention Conjunction Search Task Primary
Spatial cognition Greyscales Task Secondary
Posner Cueing Task Secondary
Spatial Working Memory Task Secondary
Cognitive performance DKEFS-Verbal Fluency Secondary
WAIS-IV-Digit Span Secondary
Continuous Performance Task Secondary
Functional ability Catherine Bergego Scale Secondary
Barthel Index Secondary
Quality of life Short Form-12 Secondary
Quality of sleep Pittsburgh Sleep Quality Index SecondarySpatial cognition
The set of secondary outcome measures in the spatial
cognition domain is comprised of performance on the
Greyscales task [37], Posner cueing task (see below), and
spatial working memory (SWM) [38]. These measures
have been empirically validated in this population and
are thought to capture components of spatial cognition,
including object-based attention (Greyscales [37]), reor-
ienting (Posner), and the online representation of spatial
locations.
Greyscales task captures perceptual bias by presenting
two mirror-reversal objects progressively darkened on
opposite ends of the object. Participants are then asked
to report which gradient seems darker. Participants with
Spatial Neglect may show a bias in judging the object
darkened on the ipsilesional side as ‘darker’ than its
mirror-reversed comparator on the majority of trials and
the critical measure is the response index indicating
Spatial Neglect.
Posner Cueing task [39] detects lateralized orienting
deficits and requires participants to detect visual stimuli
at attended or unattended peripheral locations while
maintaining central fixation. Essentially, two stimuli are
presented on left and right of the fixation point, and the
subject is cued to attend to one. This task has been used
widely in studies of Spatial Neglect, due to its sensitivity
to detect mild cases.
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spatial working memory capacity, which has been shown
to correlate with severity of neglect [38]. Participants are
presented with several possible target locations presented
centrally along the vertical meridian. Following each trail,
the participant is presented with a probe to a single lo-
cation to which they must decide if the given location
included in the possible target locations (yes/no).Cognitive performance
The set of secondary outcome measures in the cog-
nitive performance domain are comprised of tasks of
working memory and executive function. We include
these measures because executive functions have shown
to correlate with functional ability in normal healthy
populations [40]. According to principal components
analysis by Miyake [41], executive functions can be
broken down into the subdomains of working memory
updating, switching and inhibitory control.
To capture working memory updating, we will use
working memory span as an indication of updating effi-
ciency (i.e., poor updating will result in shorter span,
and vice versa). In particular, WAIS-IV Digit Span (for-
ward, backward and sequencing) is a verbal working
memory/span task, where the subject is given a list of
numbers to remember and instructed to repeat the
numbers either in the same order or in reverse order.
This task was recently updated and now includes a Digit
Span Sequencing (examinee is read a sequence of num-
bers and recalls numbers in ascending order) compo-
nent to increase the working memory demands [42].
The total raw score for Digit Span is now based on all
three components.
To capture switching ability, we will use the DKEFS
verbal fluency subtest [43]. Scoring is based on accuracy
per cue type (phonemic, semantic and category switching);
response characteristics (e.g., repetitions) are also scored.
Inhibitory control will be assessed using a continuous
performance measures with sound psychometric prop-
erties, good validity, generalizability across settings and
adaptability for trials in patients with Spatial Neglect
(similar to [44]). In general, this task requires sustained
engagement (i.e., no inter-trial break), frequent responses
and inhibitory control to over-come the proponent motor
response.Functional performance
The set of secondary outcome measures in the func-
tional performance domain is comprised of perform-
ance on the Catherine Bergego Scale [45] and the Barthel
Index [46]. We note that there is not a standardized, well-
accepted functional assessment commonly used in Spatial
Neglect treatment trials.In this trial, we will employ one of each type: a dir-
ectly observed performance measure designed to accur-
ately capture performance in Spatial Neglect (Catherine
Bergego Scale) [45], and a general clinical impression
measure (the Barthel Index). We have chosen the Catherine
Bergego Scale measure as the functional secondary measure
due to its likely sensitivity in Spatial Neglect and its
validity as a directly observed functional performance
measure [45,47].
Quality of life
A secondary outcome measure in the quality of life
of domain is comprised of performance on the Short-
Form 12 (SF-12v2) [48], a measure of Health-Related
Quality of Life. This assessment serves as a measure of
the impact of program use on the participants’ own view
of their impairment and function (i.e., quality of life).
Quality of sleep
A secondary outcome measure in the quality of sleep
domain is comprised of performance on the Pittsburg
Sleep Quality Index. This measure has been used in
many outcome studies including a prior study of TAPAT
outcomes in PTSD participants in which it effectively
captured improvements in sleep quality post-training
compared to a waitlist control group (DeGutis, in prep).
Residential status and daily activity
Exploratory analyses will be conducted on participants’
residential status and daily activity. Given the importance
of independent living status in individuals with Spatial
Neglect, we will also examine potential contribution of
participants’ immediate post acquired brain injury and
current residential status (e.g., assisted living facility, home
assisted, home unassisted) and length of hospital stay im-
mediately following insult (as well as re-admissions). We
will also examine activities pre, post, and at follow-up.
Randomization
Participants will be randomized after the baseline visit
and before the planned first day of program use. All V0
and V1 data for each participant must be fully moni-
tored, with all queries resolved, before randomization
may take place. Given the potential influence of age and
severity of spatial neglect on response to treatment, we
will create four distinct strata for each site based on age
(Adults 18–64 or Seniors ≥ 65 years of age) and severity
of spatial neglect (conjunction search outcomes equal to
or greater than 600ms difference (right threshold pres-
entation time – left threshold presentation time) is con-
sidered moderate severe, and less than 600ms, moderate
to mild neglect [29]): Adults-Severe neglect, Adults-Mild
neglect, Seniors-Severe neglect, Seniors-Mild neglect. In
particular, we will use a randomization server (http://
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procedure, and the Site Coordinating Center will issue a
randomization assignment at the appropriate time, imple-
menting an automated centralized group assignment pro-
cedure with allocation concealment.
Blinding
Un-blinded Site Roles: At each site, cognitive remediation
coaches are un-blinded in order to provide support for
participants using their assigned programs. They will be
distinct from staff administering and scoring assessments.
Additionally, site sub-investigators authorized to register
participants within the RESPONSE system will remain
un-blinded and may not participate in the assessment,
evaluation, or follow-up of study participants.
Blinded Site Roles: All site staff responsible for the ad-
ministration and scoring of participant assessments will
remain blinded to participant treatment. Site Principal
Investigators will be required to complete a Delegation
of Authority Form prior to the start of the study, indicat-
ing which activities individual site research team members
will be authorized to complete. Site Principal Investigators
will also remain blinded.
To prevent un-blinding, the following controls will
occur at the site level:
1. The treatment condition and the control condition
will be identified as “Treatment A” and “Treatment B”;
2. Participants will be reminded not to discuss details
related to treatment with psychometricians and/or
clinical evaluators during the informed consent
process as well as prior to initiation, and at the
conclusion of, each assessment visit;
3. Site personnel will be instructed to not discuss
details of either treatment arm during open
participant groups or forums;
4. Sites will be required to execute the protocol in a
manner that minimizes the possibility of accidental
un-blinding of psychometricians or clinical evaluators
(e.g., unintended viewing of treatment sessions);
5. Sites will be asked to post signage in appropriate
areas throughout the facility reminding staff and
participants to not discuss treatment details in open
locations.
At the halfway point of the trial and at the end of the
trial, psychometricians will be asked questions designed
to evaluate the integrity of the blinding procedures
employed throughout the study
Description of treatment program
The Experimental Treatment Program incorporating
TAPAT is a computerized cognitive remediation pro-
gram consisting of a set of specific cognitive exercises.Participants perform hundreds of trials over the course
of a session, with auditory and visual feedback and re-
wards to indicate if the trial was performed correctly or in-
correctly. After each session, the difficulty of the next
session is updated (e.g., less inter-stimulus-interval jitter)
to ensure that each participant is appropriately challenged.
Summary screens including game metrics (points, levels)
and exercise metrics (usage, progress) are shown to the
participant at the end of each session.
There are multiple cognitive exercises in the experimen-
tal treatment program comprised of the core exercise,
TAPAT. A description of exercises in experimental treat-
ment program is as follows:
 Tonic and Phasic Alertness Treatment (three
variations): The goals of this exercise are to improve
the individual’s intrinsic regulation of alertness and
their executive control: ability to sustain attention
and respond to successively presented stimuli in a
consistent manner (i.e., low RT variability), and
ability to inhibit the proponent motor response
when a target is presented. Exercise variants:
1) a visual category-nonspecific version; 2) a visual,
within-category version; 3) a visually engaging,
category-nonspecific version.
All training sessions will consist of the three variations
of TAPAT to provide variety during each training ses-
sion. A summary of the training schedule is provided
below.
Training schedule
Session 1: Embedded Assessments (32 min/session)
Session 2–19: TAPAT > TAPAT > TAPAT (32 min/
session)
Session 20: Embedded Assessments (32 min/session)
Session 21–38: TAPAT > TAPAT > TAPAT (32 min/
session)
Session 39: Embedded Assessments (32 min/session)
Active Control Program (commercially-available com-
puter games): The active control program is composed of
12 commercially available computer games and is de-
signed to: 1) be a face-valid approach to cognitive remedi-
ation in Spatial Neglect (analogous to crossword puzzles
for age-related cognitive decline), ensure that participants
remain blind to group affiliation, and match the experi-
mental treatment program in halo or expectation-based
influence on performance in neuropsychological outcome
measures; 2) match the experimental treatment program
in overall program use intensity, time-spent attending,
delivered rewards, and overall engagement; and 3) pro-
vide a comparison group that matches the experimental
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without the known therapeutic elements.
Data analysis
For the main analysis, we will define an Intent-To-Treat
(ITT) population that includes all participants who
complete a computer set-up visit. We will compare
treatment and active control groups in the ITT popula-
tion to determine if any differences in baseline demo-
graphic, characterization, outcomes variables, or time of
total program use remain after the randomization process.
We will test the following hypotheses, in addition to ex-
ploratory analyses: 1) Primary outcome – experimental
treatment versus active control improves spatial attention,
2) Secondary outcome – experimental treatment versus
active control improves spatial cognition, 3) Secondary
outcome – experimental treatment versus active control
improves cognitive performance, 4) Secondary outcome –
experimental treatment versus active control improves
functional performance and 5) Secondary outcome –
experimental treatment versus active control improves
quality of life. 6) Secondary outcome – experimental
treatment versus active control improves quality of
sleep. To examine each hypothesis, we will examine the
data from each outcome measure(s) associated with the
Primary or Secondary outcomes using a linear mixed-
effects model with group and time as fixed factors, site
as a random factor, and additional factors/covariates as
required if there are trends towards significant baseline
differences (p < 0.1) in the treatment and active control
groups. Missing data will be handled with an iterative
maximum likelihood procedure to optimally estimate
model parameters. The key value for significance will be
the group-by-time interaction term. This modeling will
be conducted with a Type I error set at 0.025 for each
model.
To test the hypothesis that the experimental treatment
program versus the active control program results in an
enduring effect, we will use the same modeling approach
based on the pre-training assessment (baseline) and end
of study (follow-up) assessment data using a mixed-effects
model parallel to those used to meet the primary and sec-
ondary aims. Finding a significance level of p < 0.025 on
all co-primary measures will support the hypothesis that
the training drives persistent attention as well as executive
and real-world functional improvements in this partici-
pant population above and beyond an active control.
Secondary, exploratory analysis will test for effects in
exercise-based progress as well as by domain (e.g., work-
ing memory, attention, processing speed) to determine the
unique benefit in each area of attention, cognition and
independent function. First, to determine if the treat-
ment effect varies based on participants’ clinical severity
of neglect (Conjunction search difference score: LeftTPT – Right TPT) or symptom subtype (e.g., sensory
loss vs. intact sensory systems), we will correlate neglect se-
verity (or subtype(s)) with gain scores on composite atten-
tion or executive performance and composite functional
performance (as well as individual assessment measures).
Additionally, we will measure whether improvements on
certain components of the training program (e.g., improve-
ments at inhibiting one’s response to target stimuli) are as-
sociated with composite attention, executive or functional
performance scores (as well as individual assessment
measures). This could indicate whether certain patterns
of training improvements are related more to improve-
ments in attention, executive or functional performance.
These analyses will be evaluated after correcting for
multiple comparisons (i.e., Bonferroni).Discussion
Despite experimentation with dozens of treatments for
spatial neglect over the last 50 years [49], there still does
not exist an effective, widely accepted treatment ap-
proach for this severely debilitating disorder. The current
RESPONSE protocol will help determine whether TAPAT
is effective in creating lasting deficit reduction and func-
tional improvements and will potentially provide the
building blocks for the further development and dissemin-
ation of this treatment, ultimately leading to an improved
standard of care for neglect.Strengths
One strength of TAPAT is that it targets fundamental
deficits in non-spatial attention common to nearly all
chronic neglect patients. Attesting to this, our previous
results have shown that TAPAT is effective in improving
spatial and non-spatial attention for a wide range of neg-
lect patients (especially the most severely impaired). In
addition, TAPAT is simple to perform, easy to remotely
monitor (e.g., by a clinician), and is well tolerated by pa-
tients. Because of these qualities, TAPAT can be readily
administered to many patients (with potential for remote
web-based administration) with fewer burdens on the clin-
ician than other neglect therapies (e.g., scanning training
or prism adaptation).
According to a recent systematic review of cognitive
rehabilitation for spatial neglect issues with study bias,
sample size and longitudinal effects rendered many ap-
proaches ineffective [28]. The current study is blinded and
deals with appropriate allocation concealment. Moreover,
this protocol will measure immediate as well as lasting
benefits of treatment. Lastly, many previous studies lacked
statistical power due to a small sample size. RESPONSE
will have one of the largest sample sizes of neglect treat-
ments studies, with an aim of 114 participants.
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There are also potential limitations. Due to the long
duration and multiple components of our study, attri-
tion rates may pose a potential limitation. Furthermore,
one of the common symptoms of neglect is a lack of
motivation, which could prevent timely completions of
the self-initiated training program. With a standardized
protocol, frequent check-ins, and regular feedback from
our research assistants, we aim to have a limited dropout
rate.Trial status
The trial is currently in the recruitment phase.Ethics and human research
The Western International Review Board (WIRB) is desig-
nated to review and provide continuing oversight of eth-
ical standards involving human subjects research (WIRB
Pro Number 20132014). Research is conducted in accord-
ance with the Declaration and Helsinki and monitored by
the WIRB. Participants interested in the study will meet
with qualified study staff for the consenting process, dur-
ing which the participant is informed of the nature of the
trial, purpose of research, trial procedures, risks and bene-
fits, confidentiality, etc. Following consent, the participant
will be assessed for eligibility and potential enrollment in
the trial. Minors are excluded from this study and will not
undergo the consenting process.
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